If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,140.00    182.00 (3.67%)
Bid:
5,100.00
Ask:
5,110.00
Spread: 10.00 (0.196%)
Market Cap: £18.73b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director Declaration

Today 12:20

RNS Number : 8205K
Coca-Cola HBC AG
02 July 2026
 

Coca-Cola HBC AG

Director Declaration

 

Zug, Switzerland - 2 July 2026 - Coca-Cola HBC AG ("Coca-Cola HBC") announces that Glykeria Tsernou, who is an independent non-executive director of Coca-Cola HBC, has been appointed to the board of Attica Department Stores SA.

Attica Department Stores SA shares have been listed and effective 2 July 2026 commenced trading on Euronext Athens. Glykeria Tsernou is an independent non-executive director, a member of the audit committee and a member of the remuneration and nomination committee of Attica Department Stores SA and has been appointed in these positions prior to Attica Department Stores SA's listing.

This disclosure is made in accordance with the Financial Conduct Authority's UK Listing Rule 6.4.9R.

 

 

Enquiries

Coca-Cola HBC Group

Investors and Analysts:

Jemima Benstead

Head of Investor Relations

Tel: +44 7740 535130

 jemima.benstead @cchellenic.com

Elias Davvetas

Investor Relations Manager

Tel: +30 694 7568826

elias.davvetas@cchellenic.com

Matilde Durazzano

Investor Relations Manager

 

Elizabeth King

Investor Relations Manager

 

Tel: +44 7851 105884

matilde.durazzano@cchellenic.com

 

Tel: +44 7864 686582

elizabeth.king@cchellenic.com

Media:

Claire Evans

Head of Corporate Communications

Tel: +44 7896 054 972

claire.evans @cchellenic.com

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of

The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 760 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading brands across the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories, with snacks as an additional offering. Our products include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Plazma. We foster an open and inclusive work environment for our more than 33,500 employees and believe that a positive environmental impact is integral to our future growth. We are among the leaders of the global beverage industry across major sustainability benchmarks, including the Dow Jones Best-in-Class Indices, CDP, MSCI ESG, FTSE ESG and ISS ESG.

 

Coca-Cola HBC is listed on the London Stock Exchange (LSE: CCH) and on Euronext Athens (Euronext Athens: EEE). For more information, please visit https://www.coca-colahellenic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBGGDRRUGDGLD
Date   Source Headline
18th Jan 20242:54 pmRNSDirector/PDMR Shareholding
18th Jan 20241:29 pmRNSNotice of Results
15th Jan 20244:45 pmRNSCFO stepping down to pursue new role in N. America
4th Jan 20241:45 pmRNSAthens Exchange trading date of ordinary shares
3rd Jan 202412:10 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:02 pmRNSIssue of equity and total voting rights
27th Dec 20237:15 amRNSTransaction in Own Shares
27th Dec 20237:04 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20235:35 pmRNSTransaction in Own Shares
21st Dec 20232:49 pmRNSDirector/PDMR Shareholding
20th Dec 20235:20 pmRNSTransaction in Own Shares
20th Dec 20237:15 amRNSTransaction in Own Shares
19th Dec 202312:50 pmRNSPublication of a Prospectus
19th Dec 202312:22 pmRNSDirector/PDMR Shareholding
19th Dec 20237:15 amRNSTransaction in Own Shares
15th Dec 20235:50 pmRNSTransaction in Own Shares
14th Dec 20235:45 pmRNSTransaction in Own Shares
14th Dec 20237:15 amRNSTransaction in Own Shares
13th Dec 20237:15 amRNSTransaction in Own Shares
12th Dec 20237:15 amRNSTransaction in Own Shares
11th Dec 20237:15 amRNSTransaction in Own Shares
8th Dec 20237:15 amRNSTransaction in Own Shares
7th Dec 20237:15 amRNSTransaction in Own Shares
6th Dec 20237:15 amRNSTransaction in Own Shares
5th Dec 20237:15 amRNSTransaction in Own Shares
4th Dec 20237:15 amRNSTransaction in Own Shares
1st Dec 20232:48 pmRNSDirector/PDMR Shareholding
1st Dec 20239:44 amRNSIssue of equity and total voting rights
1st Dec 20237:15 amRNSTransaction in Own Shares
30th Nov 20237:15 amRNSTransaction in Own Shares
29th Nov 20237:20 amRNSTransaction in Own Shares
28th Nov 20237:15 amRNSTransaction in Own Shares
27th Nov 20237:15 amRNSTransaction in Own Shares
24th Nov 20237:15 amRNSTransaction in Own Shares
23rd Nov 20237:15 amRNSTransaction in Own Shares
22nd Nov 202312:44 pmRNSREPLACEMENT - Transaction in Own Shares
22nd Nov 20237:15 amRNSTransaction in Own Shares
20th Nov 20234:45 pmRNSCommencement of share purchase programme
20th Nov 20234:12 pmRNSDirector/PDMR Shareholding
20th Nov 20233:29 pmRNSDirector/PDMR Shareholding
15th Nov 20233:11 pmRNSPost 2023 AGM Shareholder Engagement
9th Nov 20233:20 pmRNSDirector/PDMR Shareholding
1st Nov 20234:30 pmRNSCCH Completes the acquisition of Finlandia Vodka
1st Nov 20231:31 pmRNSBlock listing Interim Review
31st Oct 20237:00 amRNSStrong growth driving further value creation
18th Oct 20233:42 pmRNSDirector/PDMR Shareholding
5th Oct 202310:21 amRNSNotice of Results
2nd Oct 20239:23 amRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.